Purpose: Upper tract urothelial cancer is rare but studies in the 1970s sho
wed that its incidence was increasing. We evaluated national trends of the
incidence and survival of upper tract urothelial neoplasms from 1973 to 199
6.
Material and Methods: We obtained information on upper tract urothelial neo
plasms from 1973 to 1996 from the National Cancer Institute Surveillance, E
pidemiology and End Results program. To provide a time comparison we evalua
ted upper tract urothelial cancer from 1973 to 1984 and 1985 to 1996. We al
so calculated overall disease specific survival stratified by cancer stage,
patient race and gender for the study period overall.
Results: A total of 9,072 cases of upper tract urothelial cancer were ident
ified in the Surveillance, Epidemiology and End Results program from 1973 t
o 1996, including 5,379 of the renal pelvis and 3,678 of the ureter. Compar
ing age adjusted annual incidence rates revealed an increase in ureteral ne
oplasms from 0.69 to 0.73/100,000 person-years but no change in the inciden
ce of renal pelvic tumors, while the rate of in situ neoplasms increased fr
om 7.2% to 23.1%. Overall disease specific 5-year survival was significantl
y different in regard to tumor stage (95.1% in situ, 88.9% localized, 62.6%
regional and 16.5% distant lesions). Disease specific annual mortality was
greater in black than in white individuals and in women than in men (7.4%
versus 4.9% and 6.1% versus 4.4%, respectively).
Conclusions: There appears to have been a slight increase in the national i
ncidence of ureteral tumors in the last 23 years. Fortunately we also detec
ted a slight improvement in the overall disease specific survival of patien
ts with upper tract neoplasms.